Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.3M Sell
55,606
-23
-0% -$953 0.51% 56
2026
Q1
$2.3M Buy
55,629
+106
+0.2% +$4.21K 0.58% 53
2025
Q4
$2.02M Sell
55,523
-579
-1% -$20.2K 0.52% 55
2025
Q3
$1.95M Sell
56,102
-485
-0.9% -$16.1K 0.52% 59
2025
Q2
$1.85M Sell
56,587
-1,929
-3% -$58.5K 0.6% 62
2025
Q1
$1.75M Buy
58,516
+87
+0.1% +$2.59K 0.65% 53
2024
Q4
$1.52M Buy
58,429
+3,745
+7% +$97.8K 0.52% 66
2024
Q3
$1.53M Buy
54,684
+806
+1% +$22.4K 0.52% 69
2024
Q2
$1.4M Buy
53,878
+95
+0.2% +$2.57K 0.54% 69
2024
Q1
$1.58M Buy
+53,783
New +$1.53M 0.57% 66

Other funds holding ALCO

Bard Associates's ALCO Position: Q2 2026 in Review

Bard Associates reduced its Alico (ALCO) stake by 0.04% in Q2 2026, selling an estimated $953 and leaving 55,606 shares worth $2.3M. The position accounts for 0.51% of the portfolio, ranked #56.

Bard Associates first reported a position in ALCO in Q1 2024 and has held it in 10 quarters since. 111 funds tracked by Wall St. Rank hold ALCO as of Q2 2026.

  • Bard Associates held 55,606 shares of Alico worth $2.3M as of Q2 2026.
  • Bard Associates sold 23 Alico shares in Q2 2026, an estimated $953.
  • Alico made up 0.51% of Bard Associates's portfolio in Q2 2026, its #56 holding.
  • Bard Associates first reported a position in Alico in Q1 2024 and has held it in 10 quarters since.
  • 111 funds tracked by Wall St. Rank held Alico as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.